 PLYMOUTH MEETING, Pa., Aug. 9, 2021 PRNewswire -- INOVIO NASDAQ:INO, a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today reported financial results for the quarter ended June 30, 2021. 